90 related articles for article (PubMed ID: 3158701)
1. Antigenic profile and functional characterization of human peritoneal macrophages.
Mottolese M; Natali PG; Atlante G; Cavallari A; DiFilippo F; Ferrone S
J Immunol; 1985 Jul; 135(1):200-6. PubMed ID: 3158701
[TBL] [Abstract][Full Text] [Related]
2. Two distinct class II molecules encoded by the genes within HLA-DR subregion of HLA-Dw2 and Dw12 can act as stimulating and restriction molecules.
Sone T; Tsukamoto K; Hirayama K; Nishimura Y; Takenouchi T; Aizawa M; Sasazuki T
J Immunol; 1985 Aug; 135(2):1288-98. PubMed ID: 3159789
[TBL] [Abstract][Full Text] [Related]
3. Differential expression of HLA class II antigens in fetal human spleen: relationship of HLA-DP, DQ, and DR to immunoglobulin expression.
Edwards JA; Durant BM; Jones DB; Evans PR; Smith JL
J Immunol; 1986 Jul; 137(2):490-7. PubMed ID: 3522732
[TBL] [Abstract][Full Text] [Related]
4. Antigen presentation by interferon-gamma-treated endothelial cells and fibroblasts: differential ability to function as antigen-presenting cells despite comparable Ia expression.
Geppert TD; Lipsky PE
J Immunol; 1985 Dec; 135(6):3750-62. PubMed ID: 3934267
[TBL] [Abstract][Full Text] [Related]
5. Inflammatory cells infiltrating human colorectal carcinomas express HLA class II but not B7-1 and B7-2 costimulatory molecules of the T-cell activation.
Chaux P; Moutet M; Faivre J; Martin F; Martin M
Lab Invest; 1996 May; 74(5):975-83. PubMed ID: 8642792
[TBL] [Abstract][Full Text] [Related]
6. Sensitization of human lymphocytes in vitro: genetic restriction of secondary T cell responses is dictated by the HLA-DR phenotype of antigen-presenting cells.
Ford DM; Hamblin A; Burger DR
J Immunol; 1982 May; 128(5):2170-6. PubMed ID: 6977584
[TBL] [Abstract][Full Text] [Related]
7. Enhancing effect of anti-HLA class I monoclonal antibodies on T cell proliferation induced via CD2 molecule.
Turco MC; de Felice M; Corbo L; Giarrusso PC; Yang SY; Ferrone S; Venuta S
J Immunol; 1988 Oct; 141(7):2275-81. PubMed ID: 3262654
[TBL] [Abstract][Full Text] [Related]
8. Syngeneic anti-idiotypic antisera to murine anti-HLA class II monoclonal antibodies.
Perosa F; Ferrone S
J Immunol; 1987 Aug; 139(4):1232-9. PubMed ID: 3611788
[TBL] [Abstract][Full Text] [Related]
9. Influence of HLA class I- and class II-specific monoclonal antibodies on DR-restricted lymphoproliferative responses. I. Unseparated populations of effector cells.
Sterkers G; Henin Y; Kalil J; Bagot M; Levy JP
J Immunol; 1983 Dec; 131(6):2735-40. PubMed ID: 6227663
[TBL] [Abstract][Full Text] [Related]
10. Separate ontogeny of two macrophage-like accessory cell populations in the human fetus.
Janossy G; Bofill M; Poulter LW; Rawlings E; Burford GD; Navarrete C; Ziegler A; Kelemen E
J Immunol; 1986 Jun; 136(12):4354-61. PubMed ID: 3711660
[TBL] [Abstract][Full Text] [Related]
11. [Autologous mixed lymphocyte culture (AMLC)].
Volk HD; Grunow R
Allerg Immunol (Leipz); 1984; 30(2):60-73. PubMed ID: 6237558
[TBL] [Abstract][Full Text] [Related]
12. Cloned human cytotoxic T lymphocyte (CTL) lines reactive with autologous melanoma cells. I. In vitro generation, isolation, and analysis to phenotype and specificity.
de Vries JE; Spits H
J Immunol; 1984 Jan; 132(1):510-9. PubMed ID: 6197458
[TBL] [Abstract][Full Text] [Related]
13. Differential expression of HLA class II antigens on human fetal and adult lymphocytes and macrophages.
Edwards JA; Jones DB; Evans PR; Smith JL
Immunology; 1985 Jul; 55(3):489-500. PubMed ID: 3894221
[TBL] [Abstract][Full Text] [Related]
14. [Analysis of activated lymphocytes and antigen-present macrophage in human brain tumors using double immunofluorescence staining].
Kunishio K; Mishima N; Matsuhisa T; Tsuno K; Maeshiro H; Shigematsu H; Matsumi N; Matsumoto K; Furuta T; Nishimoto A
No To Shinkei; 1989 Dec; 41(12):1195-201. PubMed ID: 2697376
[TBL] [Abstract][Full Text] [Related]
15. Ia antigen on peripheral blood mononuclear leukocytes in man. II. Functional studies of HLA-DR-positive T cells activated in mixed lymphocyte reactions.
Engleman EG; Benike CJ; Charron DJ
J Exp Med; 1980 Aug; 152(2 Pt 2):114s-126s. PubMed ID: 6447741
[TBL] [Abstract][Full Text] [Related]
16. Antigen-presenting capabilities of human monocytes correlates with their expression of HLA-DS, an Ia determinant distinct from HLA-DR.
Gonwa TA; Picker LJ; Raff HV; Goyert SM; Silver J; Stobo JD
J Immunol; 1983 Feb; 130(2):706-11. PubMed ID: 6184401
[TBL] [Abstract][Full Text] [Related]
17. HLA class II molecules (HLA-DR, -DP, -DQ) on cells in the human CNS studied in situ and in vitro.
Ulvestad E; Williams K; Bø L; Trapp B; Antel J; Mørk S
Immunology; 1994 Aug; 82(4):535-41. PubMed ID: 7835916
[TBL] [Abstract][Full Text] [Related]
18. Characterization of the alloactivated E+Ia+ cell capable of stimulating in mixed lymphocyte culture.
Shen HH; Irigoyen O; Friedman SM; Chess L
J Immunol; 1982 Jan; 128(1):501-5. PubMed ID: 6459379
[TBL] [Abstract][Full Text] [Related]
19. Dendritic cells, the major antigen-presenting cells of the human colonic lamina propria.
Pavli P; Hume DA; Van De Pol E; Doe WF
Immunology; 1993 Jan; 78(1):132-41. PubMed ID: 8436399
[TBL] [Abstract][Full Text] [Related]
20. Antibodies reactive with class II antigens encoded for by the major histocompatibility complex inhibit human B cell activation.
Clement LT; Tedder TF; Gartland GL
J Immunol; 1986 Apr; 136(7):2375-81. PubMed ID: 3485149
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
